Physician
Miami Children's Hospital Pathologists, PA
Miami Children's Hospital Pathologists, PA was paid $10.42M by Medicaid between Jan 2018 and Dec 2024, across 183 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 16% of everything it billed.
33Billing provider infoMIAMI CHILDREN'S HOSPITAL PATHOLOGISTS, PA
MIAMI, FL 33155
MIAMI, FL 33155
33aNPI1205800638assigned 02/14/2006
33bProvider typeCytopathology Physician
28Total paid$10.42M
24GClaims1,771,558
24DCodes billed183
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Cytopathology Physician providers in Florida
Rank by total paid#1 of 14
Median peer was paid$776K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 59,714 | $95K | |
| 2019 | 233,049 | $743K | |
| 2020 | 220,773 | $984K | |
| 2021 | 265,972 | $1.76M | |
| 2022 | 347,235 | $2.22M | |
| 2023 | 396,522 | $2.76M | |
| 2024incomplete | 248,293 | $1.86M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 16% | 16,212 | 14,948 | $1.63M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 12% | 7,944 | 7,429 | $1.28M |
| 82805 | 12% | 71,403 | 12,993 | $1.24M | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 9.0% | 66,865 | 63,797 | $939K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 6.9% | 28,820 | 23,915 | $717K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.8% | 40,860 | 39,163 | $607K |
| 87507 | 4.7% | 6,212 | 5,334 | $493K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.7% | 25,933 | 23,780 | $490K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.8% | 153,503 | 86,726 | $397K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.9% | 66,616 | 29,307 | $194K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.8% | 11,439 | 9,619 | $186K |
| 87486 | 1.3% | 25,102 | 22,921 | $134K |
171 more codes
| 87581 | 1.2% | 27,397 | $130K | |
| 85027 | 1.2% | 127,423 | $121K | |
| 80053 | Comprehensive metabolic panel | 1.1% | 47,994 | $120K |
| 82330 | <1% | 33,974 | $81K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,192 | $79K |
| 82947 | <1% | 54,340 | $71K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 17,411 | $70K |
| 87807 | <1% | 21,282 | $68K | |
| 80306 | <1% | 4,085 | $62K | |
| 81001 | <1% | 56,440 | $55K | |
| 88312 | <1% | 3,642 | $54K | |
| 87040 | <1% | 25,311 | $54K | |
| 83605 | <1% | 28,321 | $52K | |
| 85007 | <1% | 99,091 | $51K | |
| 86140 | <1% | 51,481 | $47K | |
| 87186 | <1% | 12,626 | $45K | |
| 88304 | <1% | 3,381 | $45K | |
| 83735 | <1% | 41,136 | $44K | |
| 87070 | <1% | 21,222 | $32K | |
| 86920 | <1% | 1,646 | $31K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 32,883 | $28K |
| 80047 | <1% | 10,360 | $27K | |
| 81025 | <1% | 20,439 | $26K | |
| 86850 | <1% | 11,917 | $25K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,338 | $25K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 8,294 | $24K |
| 83880 | <1% | 2,387 | $24K | |
| 87150 | <1% | 447 | $22K | |
| 80069 | <1% | 17,908 | $22K | |
| 84132 | <1% | 31,973 | $21K | |
| 85014 | <1% | 38,806 | $21K | |
| 84295 | <1% | 31,324 | $21K | |
| 80076 | <1% | 19,216 | $21K | |
| 87641 | <1% | 2,842 | $21K | |
| 84145 | <1% | 16,070 | $20K | |
| 84100 | <1% | 28,421 | $19K | |
| 87077 | <1% | 14,690 | $18K | |
| 85018 | <1% | 35,943 | $17K | |
| 86665 | <1% | 2,894 | $17K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 446 | $17K |
| 86480 | <1% | 1,073 | $17K | |
| 83970 | <1% | 1,123 | $17K | |
| 87529 | <1% | 1,833 | $15K | |
| 80202 | <1% | 3,739 | $14K | |
| 87181 | <1% | 4,558 | $12K | |
| 85730 | <1% | 13,318 | $12K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 1,440 | $11K |
| 85610 | <1% | 14,608 | $10K | |
| 86664 | <1% | 2,534 | $9K | |
| 87640 | <1% | 2,195 | $9K | |
| 84439 | <1% | 8,098 | $9K | |
| 87206 | <1% | 1,519 | $9K | |
| 82784 | <1% | 4,946 | $8K | |
| 87045 | <1% | 3,885 | $8K | |
| 87205 | <1% | 9,929 | $7K | |
| 82962 | <1% | 6,190 | $7K | |
| 86901 | <1% | 11,968 | $7K | |
| 83690 | <1% | 8,300 | $7K | |
| 88300 | <1% | 2,163 | $6K | |
| 82550 | <1% | 7,520 | $6K | |
| 86900 | <1% | 11,640 | $6K | |
| 82247 | <1% | 4,747 | $5K | |
| 84484 | <1% | 3,124 | $5K | |
| 83615 | <1% | 7,196 | $5K | |
| 85652 | <1% | 11,999 | $5K | |
| 85384 | <1% | 4,017 | $5K | |
| 82728 | <1% | 3,152 | $5K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,415 | $4K |
| 82610 | <1% | 1,992 | $4K | |
| 86360 | <1% | 285 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,413 | $4K |
| 85576 | <1% | 139 | $4K | |
| 86160 | <1% | 814 | $4K | |
| 80061 | Lipid panel | <1% | 1,881 | $4K |
| 84156 | <1% | 2,570 | $3K | |
| 85045 | <1% | 5,741 | $3K | |
| 81003 | <1% | 5,007 | $3K | |
| 80074 | <1% | 188 | $3K | |
| 82150 | <1% | 3,641 | $3K | |
| 87427 | <1% | 2,360 | $3K | |
| 80197 | <1% | 588 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,085 | $2K |
| 87255 | <1% | 95 | $2K | |
| 84146 | <1% | 383 | $2K | |
| 82533 | <1% | 597 | $2K | |
| 89050 | <1% | 2,945 | $2K | |
| 87503 | <1% | 278 | $2K | |
| 87075 | <1% | 1,430 | $2K | |
| 82945 | <1% | 2,634 | $2K | |
| 80329 | <1% | 522 | $2K | |
| 87498 | <1% | 592 | $2K | |
| 84157 | <1% | 2,533 | $2K | |
| 82248 | <1% | 2,792 | $2K | |
| 84480 | <1% | 184 | $2K | |
| 87116 | <1% | 1,289 | $2K | |
| 87653 | <1% | 595 | $2K | |
| 82810 | <1% | 754 | $2K | |
| 85520 | <1% | 1,171 | $2K | |
| 87102 | <1% | 1,502 | $2K | |
| 87496 | <1% | 585 | $2K | |
| 88108 | <1% | 96 | $2K | |
| 84550 | <1% | 2,727 | $2K | |
| 82785 | <1% | 910 | $2K | |
| 82977 | <1% | 1,566 | $2K | |
| 87532 | <1% | 645 | $2K | |
| 84478 | <1% | 1,924 | $2K | |
| 83525 | <1% | 94 | $1K | |
| 87209 | <1% | 219 | $1K | |
| 85379 | <1% | 1,232 | $1K | |
| 85300 | <1% | 1,134 | $1K | |
| 80050 | General health panel | <1% | 32 | $1K |
| 86235 | <1% | 48 | $1K | |
| 86738 | <1% | 444 | $1K | |
| 82570 | <1% | 1,022 | $1K | |
| 87177 | <1% | 797 | $1K | |
| 83540 | <1% | 1,558 | $1K | |
| 86308 | <1% | 1,946 | $1K | |
| 87015 | <1% | 1,237 | $1K | |
| 82565 | <1% | 1,825 | $1K | |
| 83550 | <1% | 1,086 | $1K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 221 | $1K |
| 82140 | <1% | 514 | $1K | |
| 80051 | <1% | 102 | $911.11 | |
| 84520 | <1% | 1,375 | $821.33 | |
| 84134 | <1% | 297 | $805.32 | |
| 82010 | <1% | 904 | $699.12 | |
| 82607 | <1% | 327 | $698.08 | |
| 86644 | <1% | 231 | $678.48 | |
| 82435 | <1% | 475 | $635.11 | |
| 86039 | <1% | 288 | $582.53 | |
| 85347 | <1% | 255 | $563.60 | |
| 87340 | <1% | 218 | $560.17 | |
| 86355 | <1% | 341 | $531.24 | |
| 86769 | <1% | 196 | $507.11 | |
| 82040 | <1% | 868 | $483.87 | |
| 82272 | <1% | 794 | $479.00 | |
| 80164 | <1% | 122 | $432.90 | |
| 86357 | <1% | 341 | $424.17 | |
| 82746 | <1% | 194 | $403.73 | |
| 87081 | <1% | 339 | $398.30 | |
| 86359 | <1% | 331 | $390.79 | |
| 84481 | <1% | 60 | $370.70 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 85 | $292.06 |
| 81306 | <1% | 12 | $285.53 | |
| 86645 | <1% | 135 | $228.22 | |
| 88342 | <1% | 14 | $186.48 | |
| 81231 | <1% | 12 | $171.31 | |
| 81232 | <1% | 12 | $171.31 | |
| 81328 | <1% | 12 | $171.31 | |
| 81335 | <1% | 12 | $171.31 | |
| 84702 | <1% | 58 | $166.26 | |
| 82374 | <1% | 95 | $95.44 | |
| 86060 | <1% | 92 | $89.87 | |
| 82340 | <1% | 60 | $62.12 | |
| 81015 | <1% | 241 | $60.48 | |
| 86787 | <1% | 30 | $57.71 | |
| 86038 | <1% | 63 | $39.79 | |
| 82553 | <1% | 72 | $34.02 | |
| 86803 | <1% | 13 | $33.36 | |
| 86880 | <1% | 16 | $23.63 | |
| 84436 | <1% | 42 | $23.43 | |
| 82310 | <1% | 45 | $21.04 | |
| 84300 | <1% | 86 | $18.47 | |
| 87252 | <1% | 36 | $18.25 | |
| 86706 | <1% | 14 | $17.59 | |
| 87634 | <1% | 827 | $14.73 | |
| 87254 | <1% | 52 | $12.86 | |
| 84460 | <1% | 29 | $7.29 | |
| 83935 | <1% | 21 | $4.52 | |
| 84450 | <1% | 14 | $4.05 | |
| 87338 | 0% | 307 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMELNICK, STEVEN (DIRECTOR)